Hearing Loss and Alzheimer’s: New Research on Risk Factors

The number of people living with Alzheimer’s disease is projected to double by 2060, according to data from the Alzheimer’s Association. Researchers at the Johns Hopkins Bloomberg School of Public Health have identified hearing loss, sleep disturbances, and metabolic health as primary, modifiable risk factors that may influence the trajectory of cognitive decline. Addressing these … Read more

Visceral Fat: Health Risks and How to Reduce It

Visceral fat is an active, inflammatory type of adipose tissue stored deep within the abdominal cavity, surrounding vital organs such as the heart, liver, and kidneys. According to the Cleveland Clinic, while moderate amounts are normal, excessive visceral fat releases inflammatory proteins linked to cardiovascular disease, Type 2 diabetes, and stroke. Experts report that this … Read more

Missing Woman Found Deceased: Body Identified

The body of Elena Moore, a 39-year-old personal trainer reported missing last week, has been positively identified in Lexington County, South Carolina. Officials confirmed the identification on Friday after a body matching Moore’s description was discovered on Wednesday. The South Carolina Law Enforcement Division (SLED) has assumed the investigation into the circumstances of her death. … Read more

Kali365 Security Warning: Teams, Outlook, and OneDrive at Risk

The FBI has issued an urgent security warning regarding Kali365, a new “Phishing-as-a-Service” platform that allows attackers to bypass Microsoft 365 multi-factor authentication (MFA). By targeting OAuth device codes, scammers can gain unauthorized access to Outlook, Teams, and OneDrive accounts without ever needing a user’s password. How does the Kali365 scam bypass multi-factor authentication? Scammers … Read more

Is It Safe to Stop and Restart GLP-1 Treatments?

More than half of patients who stop GLP-1 weight-loss treatments are likely to restart them within a year, according to a study by the Endocrine Society. While many attempt to resume medications like Ozempic or Wegovy, research published in the Journal of Clinical Investigation Insight suggests that inconsistent dosing may reduce how effective these drugs … Read more

The ‘Pharmaceutical Mafia’ Crisis: Why Life-Saving Drugs Are Unaffordable

As the conflict in Iran persists, the nation faces a severe humanitarian crisis marked by acute medicine shortages, soaring inflation, and a restrictive information environment. According to reports from NewsNation and data from the Iranian Human Pharmaceutical Industry Syndicate, the country’s pharmaceutical reserves are nearing depletion, with approximately 200 essential medical items currently in short … Read more

Why US Alcohol Guidelines Ignored New Government Risk Study

A government-commissioned study released Tuesday in the Journal of Studies on Alcohol and Drugs concludes that no level of alcohol consumption offers a protective health benefit, with risks of premature death and over 200 diseases rising even with one drink per day. The findings, originally commissioned under the Biden administration, were released independently after internal … Read more

Can Ozempic and Wegovy Slow Biological Aging?

Semaglutide might do more than manage weight; it could potentially slow biological aging. According to research from UC San Diego’s School of Medicine, the drug—marketed as Ozempic and Wegovy—showed the ability to slow the pace of biological aging by approximately 9% in a study of adults with HIV-associated lipohypertrophy. How does semaglutide impact biological aging? … Read more

Why AI Can’t Replace Authors: An Interview with David Szalay

The Future of Fiction: Why Human Embodiment Remains Our Greatest Literary Asset In an era where artificial intelligence can generate grammatically perfect prose in seconds, the literary world is undergoing a profound identity crisis. Author David Szalay, whose Booker Prize-winning novel Flesh explores the raw, physical reality of existence, recently noted a crucial distinction: AI … Read more